Ignite Creation Date:
2025-12-24 @ 7:24 PM
Ignite Modification Date:
2025-12-25 @ 5:04 PM
Study NCT ID:
NCT04302103
Status:
COMPLETED
Last Update Posted:
2023-10-11
First Post:
2020-03-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of TACI（Transmembrane Activator and Calcium-modulator and Cyclophilin Ligand (CAML) Interactor）-Antibody Fusion Protein Injection (RC18) in Subjects With Systemic Myasthenia Gravis
Sponsor:
RemeGen Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07-07
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-02-11
Completion Date Type:
ACTUAL
First Submit Date:
2020-03-06
First Submit QC Date:
None
Study First Post Date:
2020-03-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-10
Last Update Post Date:
2023-10-11
Last Update Post Date Type:
ACTUAL